Restatement of Previously Issued Financial Statements

3 Months Ended

Mar. 31, 2022

Accounting Changes and Error Corrections [Abstract]

Restatement of Previously Issued Financial Statements

NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

Management identified errors made in its historical financial statements for the accounting of accruals.

The following tables summarize the effect of the restatement on each financial statement line item as of the dates, and for the periods, indicated:

	As previously reported			Adjustments			As restated
Balance Sheet – March 31, 2022
Accounts payable and accrued expenses	$	460,243		$	2,232,918		$	2,693,161
Total current liabilities		460,243			2,232,918			2,693,161
Total liabilities		9,528,101			2,232,918			11,761,019
Shareholders’ deficit
Accumulated deficit		(8,746,925	)		(2,232,918	)		(10,979,843	)
Total shareholders’ deficit	$	(8,746,503	)	$	(2,232,918	)	$	(10,979,421	)

	As Previously Reported		Adjustments			As restated
Statement of Operations – For the Three Months ended March 31, 2022
General and administrative expenses	$	1,081,739		1,178,130			2,259,869
Total expenses		1,111,739		1,178,130			2,289,869
Net income		8,801,020		(1,178,130	)		7,622,890
Basic and diluted weighted average shares outstanding, redeemable Class A ordinary shares		16,900,000		—			16,900,000
Basic and diluted net income per share of redeemable Class A ordinary shares	$	0.42	$	(0.06	)	$	0.36
Weighted average number shares of non-redeemable ordinary shares outstanding, basic and diluted		4,225,000		—			4,225,000
Basic and diluted net income per share of non-redeemable ordinary shares	$	0.42	$	(0.06	)	$	0.36